NDLI: Probiotics and irritable bowel syndrome

Please wait, while we are loading the content...

Volume 30, 2019

Volume 29, 2018

Volume 28, 2017

Volume 27, 2016

Volume 26, 2015

Volume 25, 2014

Volume 24, 2013

Volume 23, 2012

Volume: 23 Issue: 4

Molecular ecology in Health and Disease

Intestinal cytochromes P450 regulating the intestinal microbiota and its probiotic profile

Gut indigenous microbiota and epigenetics

The effect of a commercial probiotic drink on oral microbiota in healthy complete denture wearers

Correlations between Lumbricus terrestris survival and gut microbiota

A ten years (2000–2009) surveillance of resistant Enterobacteriaceae in Zhejiang Province, China

Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Concentration of circulating autoantibodies against HSP 60 is lowered through diving when compared to non-diving rats

Editorial: The gut and the brain – with focus on autism spectrum disorders: Microbial Ecology in Health and Disease: Vol 23, No 1

A true case story: Microbial Ecology in Health and Disease: Vol 23, No 1

Longitudinal high-risk sibling studies of autism spectrum disorder

Autism spectrum disorder, functional MRI and MR spectroscopy: possibilities and challenges: Microbial Ecology in Health and Disease: Vol 23, No 1

The gut: a triggering place for autism – possibilities and challenges

Commensal communication to the brain: pathways and behavioral consequences

Peptides’ role in autism with emphasis on exorphins: Microbial Ecology in Health and Disease: Vol 23, No 1

Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders: Microbial Ecology in Health and Disease: Vol 23, No 1

Should autism be considered a canary bird telling that Homo sapiens may be on its way to extinction?

Abstracts from the Joint 17th ISG/34th SOMED Meeting in Yokohama, 1922 May 2011 - complete supplement: Microbial Ecology in Health and Disease: Vol 23, No 1

Abstracts from the Joint 17th ISG/34th SOMED Meeting in Yokohama, 19-22 May 2011

Symposium presentations

Enhancing probiotic stability in industrial processes: Microbial Ecology in Health and Disease: Vol 23, No 1

Fructophilic lactic acid bacteria inhabit fructose-rich niches in nature

Probiotic viability – does it matter?: Microbial Ecology in Health and Disease: Vol 23, No 1

Kiwifruit (Actinidia deliciosa) changes intestinal microbial profile

Probiotics and irritable bowel syndrome

Gut microbiota and infant distress – the association between compositional development of the gut microbiota and fussing and crying in early infancy

Isolation of bifidobacteria for blood group secretor status targeted personalised nutrition: Microbial Ecology in Health and Disease: Vol 23, No 1

Defining microbiota for developing new probiotics

Probiotics and prebiotics: health claim substantiation

Nutrition economic evaluation of allergy treatment in infants and children: background for probiotic studies: Microbial Ecology in Health and Disease: Vol 23, No 1

Nutrition economics: towards comprehensive understanding of the benefits of nutrition: Microbial Ecology in Health and Disease: Vol 23, No 1

Fermented milk containing Lactobacillus GG alleviated DSS-induced colitis in mice and activated epidermal growth factor receptor and Akt signaling in intestinal epithelial cells: Microbial Ecology in Health and Disease: Vol 23, No 1

Abstract: Overview of technology developments in probiotic field: Microbial Ecology in Health and Disease: Vol 23, No 1

Abstract: Prebiotics and probiotics – the importance of branding

Abstract: Probiotics and atherosclerosis – a new challenge?

Abstract: Probiotics and dental caries

Abstract: Prebiotic developments

Abstract: Health claims on foods: challenge for clinical research companies

Akivo Lenzner, 1927–2012

Volume: 23 Issue: 3

Volume: 23 Issue: 2

Volume: 23 Issue: 1

Volume 22, 2011

Volume 21, 2009

Volume 20, 2008

Volume 19, 2007

Volume 18, 2006

Volume 17, 2005

Volume 16, 2004

Volume 15, 2003

Volume 14, 2002

Volume 13, 2001

Volume 12, 2000

Volume 11, 1999

Volume 10, 1999

Probiotics and irritable bowel syndrome

Content Provider	Taylor & Francis Online
Author	Niittynen, Leena Korpela, Riitta
Abstract	Background : Irritable bowel syndrome (IBS) is a major cause of abdominal discomfort and gut dysfunction worldwide. It is a poorly understood functional gastrointestinal disorder for which no effective medication is available. It is a benign condition, but its social and economic burden is significant. The symptoms consist of abdominal pain, bloating, flatulence, and irregular bowel movements. Alterations in the intestinal microbiota and mucosal inflammation may contribute to the development of IBS and probiotics could thus relieve the symptoms. This review gives an overview on the existing data on the effects of probiotics on the gastrointestinal symptoms of IBS. Methods : A PUBMED search was made to review the relevant literature, and additional studies were obtained from the references of the selected articles. Results : Clinical trials suggest that certain probiotics or combinations of bacteria have beneficial effects on the IBS symptoms. However the heterogeneity of studies, e.g. suboptimal study design, inadequate number of subjects, different doses and vehicles, inadequate length, make it difficult to compare the differences between probiotics and the effect may be strain-specific. Conclusions : Though evidence is very promising, no general recommendations on the use of probiotics in IBS can be given yet. Further clinical trials and data on the mechanisms of action are needed. Probiotics are considered safe and if future scientific data is able to substantiate their efficacy in IBS, they certainly could be a treatment option in relieving the symptoms in IBS.
File Format	PDF HTM / HTML
Journal	Microbial Ecology in Health and Disease
Volume Number	23
Issue Number	1
Language	English
Publisher	Taylor & Francis
Publisher Date	2012-06-18
Access Restriction	Open
Subject Keyword	IBS Probiotic Irritable bowel syndrome Gastrointestinal symptoms Lactobacilli Bifidobacteria
Content Type	Text
Resource Type	Article

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in